Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1517502
PUBLISHER: BCC Research | PRODUCT CODE: 1517502
Metabolomics: Technologies and Global Markets
PUBLISHED:
PAGES: 99 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.
The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.
Report Scope
This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Includes
- 32 data tables and 39 additional tables
- An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
- Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
- A look at ESG trends
- Information on developments in R&D, clinical trials, emerging technologies, and economic trends
- Analysis of key companies' market shares, proprietary technologies, patents, and alliances
- Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA
Product Code: BIO055E
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Overview of Metabolomics
- Separation Techniques
- Detection Techniques
- Metabolites and Their Applications
- R&D and Regulatory Approval
- Supply Chain Analysis
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Technological Advancements
- Increasing Healthcare Expenditure
- Expanding Applications Across Industries
- Market Restraints
- High Cost of Instruments and Services
- Complexity of Data Analysis
- Standardization and Quality Control Challenges
- Limited Biomarker Validation and Clinical Utility
- Market Opportunities
- Precision Medicine and Personalized Healthcare
- Drug Discovery and Development
- Biomarker Discovery and Validation
- Nutritional Profiling and Functional Foods
- Environmental Monitoring and Toxicology
- Market Challenges
- Data Complexity and Interpretation
- Standardization and Quality Assurance
- Biomarker Validation and Clinical Translation
- Technological Limitations and Costs
- Regulatory and Ethical Considerations
Chapter 4 Emerging Technologies and Developments
- Introduction
- Clinical Trial Analysis
- By Study Type
- By Status
- By Gender
- By Interventions
- Granted Patents
- Introduction
- Patent Analysis
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Metabolomics Market, by Product
- Global Market Analysis and Forecast
- Separation Techniques
- Detection Techniques
- Metabolomics Market, by Indication
- Global Market Analysis and Forecast
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Diseases Indication
- Metabolomics Market, by Application
- Global Market Analysis and Forecast
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Others
- Geographic Breakdown
- Metabolomics Market, by Region
- Global
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Company Share Analysis
- Strategic Analysis
- Mergers and Acquisitions
- Venture Capital Funding
Chapter 7 Appendix
- Methodology
- Sources
- Acronyms
- Definitions/Taxonomy
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP.
- MERCK KGAA
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
Product Code: BIO055E
List of Tables
- Summary Table : Global Market for Metabolomics Technologies, by Product, Through 2029
- Table 1 : Publications Referencing Metabolomics, 2021-2023
- Table 2 : Mass Spectrometry Products from Different Global Players
- Table 3 : Prices of Mass Spectrometry Products from Different Global Players
- Table 4 : Mass Spectrometry Steps to Metabolite Identification
- Table 5 : Various Metabolites and Their Functions and Applications
- Table 6 : Metabolomics Supply Chain
- Table 7 : Metabolomics Supply Chain Examples
- Table 8 : List of Bioinformatics Tools Used in Metabolomics
- Table 9 : List of Biomarkers Used in the Metabolomics and Applications
- Table 10 : Global Regulatory and Ethical Considerations for Metabolomics-Based Products
- Table 11 : Metabolomics Emerging Technologies
- Table 12 : Selected Clinical Trials Data for Metabolomics, 2021-2024
- Table 13 : Selected Granted Patents of Metabolomics, 2022 and 2023
- Table 14 : Global Market for Metabolomics Technologies, by Product, Through 2029
- Table 15 : Global Market for Separation Techniques in Metabolomics Technologies, by Region, Through 2029
- Table 16 : Global Market for Detection Techniques in Metabolomics Technologies, by Region, Through 2029
- Table 17 : Global Market for Metabolomics Technologies, by Disease Indication, Through 2029
- Table 18 : Global Market for Metabolomics Technologies for Cancer Indication, by Region, Through 2029
- Table 19 : Global Market for Metabolomics Technologies for Cardiovascular Disorders, by Region, Through 2029
- Table 20 : Global Market for Metabolomics Technologies for Neurological Disorders, by Region, Through 2029
- Table 21 : Global Market for Metabolomics Technology for Inborn Errors of Metabolism, by Region, Through 2029
- Table 22 : Global Market for Metabolomics Technologies for Other Diseases Indication, by Region, Through 2029
- Table 23 : Global Market for Metabolomics Technologies, by Application, Through 2029
- Table 24 : Global Market for Metabolomics Technologies in Biomarker Discovery, by Region, Through 2029
- Table 25 : Global Market for Metabolomics Technologies in Drug Discovery, by Region, Through 2029
- Table 26 : Global Market for Metabolomics Technologies in Toxicology Testing, by Region, Through 2029
- Table 27 : Global Market for Metabolomics Technologies in Nutrigenomics, by Region, Through 2029
- Table 28 : Global Market for Metabolomics Technologies in Functional Genomics, by Region, Through 2029
- Table 29 : Global Market for Metabolomics Technologies in Other Applications, by Region, Through 2029
- Table 30 : Global Market for Metabolomics Technologies, by Region, Through 2029
- Table 31 : North American Market for Metabolomics Technologies, by Country, Through 2029
- Table 32 : European Market for Metabolomics Technologies, by Country, Through 2029
- Table 33 : Asia-Pacific Market for Metabolomics Technologies, by Country, Through 2029
- Table 34 : Rest of the World Market for Metabolomics Technologies, Through 2029
- Table 35 : Merger and Acquisitions in the Global Market for Metabolomics Technologies, 2023
- Table 36 : Funded Projects for Metabolomics Technologies, 2021-2024
- Table 37 : Report Sources
- Table 38 : Major Acronyms Used in This Report
- Table 39 : Agilent Technologies Inc.: Company Snapshot
- Table 40 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
- Table 41 : Agilent Technologies Inc.: Product Portfolio
- Table 42 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
- Table 43 : Bio-Rad Laboratories Inc.: Company Snapshot
- Table 44 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
- Table 45 : Bio-Rad Laboratories Inc.: Product Portfolio
- Table 46 : Bio-Rad Laboratories Inc.: News/Key Developments, 2023 and 2024
- Table 47 : Bruker: Company Snapshot
- Table 48 : Bruker: Financial Performance, FY 2022 and 2023
- Table 49 : Bruker: Product Portfolio
- Table 50 : Bruker: News/Key Developments, 2023
- Table 51 : Danaher Corp.: Company Snapshot
- Table 52 : Danaher Corp.: Financial Performance, FY 2022 and 2023
- Table 53 : Danaher Corp.: Product Portfolio
- Table 54 : Danaher Corp.: News/Key Developments, 2023 and 2024
- Table 55 : Merck KGaA: Company Snapshot
- Table 56 : Merck KGaA: Financial Performance, FY 2022 and 2023
- Table 57 : Merck KGaA: Product Portfolio
- Table 58 : Merck KGaA: News/Key Developments, 2023
- Table 59 : Shimadzu Corp.: Company Snapshot
- Table 60 : Shimadzu Corp.: Financial Performance, FY 2021 and 2022
- Table 61 : Shimadzu Corp.: Product Portfolio
- Table 62 : Shimadzu Corp.: News/Key Developments, 2023
- Table 63 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 64 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
- Table 65 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 66 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
- Table 67 : Waters Corp.: Company Snapshot
- Table 68 : Waters Corp.: Financial Performance, FY 2022 and 2023
- Table 69 : Waters Corp.: Product Portfolio
- Table 70 : Waters Corp.: News/Key Developments, 2023
List of Figures
- Summary Figure : Global Market for Metabolomics Technologies, by Product, 2024-2029
- Figure 1 : Publications Referencing Metabolomics, 2021-2023
- Figure 2 : Different Metabolomics Techniques
- Figure 3 : Schematic Diagram of Mass Spectrometry
- Figure 4 : Market Dynamics of Global Metabolomics Technologies
- Figure 5 : Global Healthcare Expenditure, 2021-2023
- Figure 6 : Global Shares of Metabolomics Clinical Trials, by Study, 2024
- Figure 7 : Global Shares of Metabolomics Clinical Trials, by Status, 2024
- Figure 8 : Global Shares of Metabolomics Clinical Trials, by Gender, 2024
- Figure 9 : Global Metabolomics Clinical Trials, by Interventions, 2024
- Figure 10 : Selected Granted Patents Involving Metabolomics, by Applicant, 2022 and 2023
- Figure 11 : Global Market Shares of Metabolomics Technologies, by Product, 2023
- Figure 12 : Global Market Shares of Metabolomics Technologies, by Disease Indication, 2023
- Figure 13 : Global Market Shares of Metabolomics Technologies, by Application, 2023
- Figure 14 : Global Market Shares of Metabolomics Technologies, by Region, 2023
- Figure 15 : North American Market Shares of Metabolomics Technologies, by Country, 2023
- Figure 16 : European Market Shares of Metabolomics Technologies, by Country, 2023
- Figure 17 : Asia-Pacific Market Shares of Metabolomics Technologies, by Country, 2023
- Figure 18 : Global Market Shares of Metabolomics Technologies, by Company, 2023
- Figure 19 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
- Figure 20 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
- Figure 21 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
- Figure 22 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
- Figure 23 : Bruker: Revenue Shares, by Business Unit, FY 2023
- Figure 24 : Bruker: Revenue Shares, by Country/Region, FY 2023
- Figure 25 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
- Figure 26 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
- Figure 27 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023
- Figure 28 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
- Figure 29 : Shimadzu Corp.: Revenue Shares, by Business Unit, FY 2022
- Figure 30 : Shimadzu Corp.: Revenue Shares, by Country/Region, FY 2022
- Figure 31 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
- Figure 32 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
- Figure 33 : Waters Corp.: Revenue Shares, by Business Unit, FY 2023
- Figure 34 : Waters Corp.: Revenue Shares, by Country/Region, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.